Understanding how immune cells respond to signals in their environment

Signal Integration during Phagocytosis

NIH-funded research University of California Santa Barbara · NIH-11075223

This study is looking at how immune cells called macrophages recognize and react to germs that are marked by a specific antibody, helping us understand how they decide when to fight off infections and when to stay calm, which is important for keeping our bodies healthy.

Quick facts

Grant typeNIH-funded research
Study typeNIH-funded research
Funding institutionUniversity of California Santa Barbara NIH-funded
Lab location1 site (Santa Barbara, United States)
Project IDNIH-11075223 on NIH RePORTER

What this research studies

This research investigates how macrophages, a type of immune cell, detect and respond to various signals in their environment, particularly focusing on IgG-bound pathogens. The study aims to define the mechanisms that determine how sensitive these cells are to external stimuli, which is crucial for their role in immune responses. Researchers will explore how the clustering of receptors on macrophages influences their ability to initiate processes like phagocytosis and inflammation. By examining both activating and inhibitory signals, the research seeks to uncover the balance that macrophages maintain to effectively respond to threats while avoiding unnecessary reactions to healthy cells.

Who could benefit from this research

Good fit: Ideal candidates for this research are individuals with conditions that involve immune system responses, such as autoimmune diseases or chronic infections.

Not a fit: Patients with conditions unrelated to immune system function or those not experiencing immune-related symptoms may not benefit from this research.

Why it matters

Potential benefit: If successful, this research could lead to improved therapies for diseases involving immune dysfunction, such as autoimmune disorders and infections.

How similar studies have performed: Previous research has shown promising results in understanding immune cell signaling, suggesting that this approach could yield valuable insights.

Where this research is happening

Santa Barbara, United States

Researchers

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Last reviewed 2026-06-13 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.